J&J raises FY26 outlook following positive Q2
Johnson and Johnson (J&J) has achieved Q2 revenues totalling around $25.3bn, representing a year-over-year (YoY) uptick of 6.6%, with the…
Johnson and Johnson (J&J) has achieved Q2 revenues totalling around $25.3bn, representing a year-over-year (YoY) uptick of 6.6%, with the…
The US Food and Drug Administration (FDA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will more formally…
In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma…
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister…
Last week, data from 500,000 participants of UK Biobank’s database were made available for sale online following a breach, the…
Boehringer Ingelheim has launched a new artificial intelligence (AI) and machine learning (ML) centre in London, representing the company’s latest…
Contract Development and Manufacturing Organisations’ (CDMOs) expansion into more complex biopharmaceuticals, gene therapy and advanced product sectors is prompting a…
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic…
Ryan Rotar, vice president of healthcare market strategy at Tecsys, outlines how supply chain resilience can be maintained in the…
With the recent conclusion of PharmaPack 2026, this month’s magazine is focused on the key messaging that emanated from the event. With…